JAMA Psych: Low doses of aspirin may not reduce the risk of depression in older people

, June 10, 2020 /

/BIOON/ -- In a recent study published in the international journalthe Journal of, scientists from the Deakin University School of Medicine and others found that low-dose aspirin may not reduce their risk ofdepression in older adultsPhoto Source: medicalxpress.com
In the paper, the researchers conducted a double-blind trial to determine the effect of low-dose aspirin (100 mg) on therisk ofdepression in healthy older populations, including older Australians over 70 years of age, and black and Hispanic older americans over 70 years of age in the United States, with 19,114 participants enrolled in the study, 9,525 participants receiving aspirin treatment, and 9,589 participants receiving placebo therapy, with an average duration of 7.7researchers found that when participants in the aspirin and placebo groups visited each year, there was no significant difference in the proportion
of 10 of depression (CES-D-10) scored by the epidemiological research centerdepression; The 0-plus event rate was 70.4 and 69.1 per 1,000 people per year (danger ratio: 1.02; 95% confidence interval: 0.96-1.08; p-0.54)researchers say the study does not confirm any potential benefits of low-dose aspirin in reducing
the risk of depressionin a relatively healthy population of older adultsLater researchers also need to delve into why low-dose aspirin does nare to reduce the risk of depression in older adults(BioValleyBioon.com) original origins: Michael Berk, Robyn L Woods, Mark R Nelson, et al al of TheEffect of The Sie-Aspirin vs Placebo on the The Prevention of The Great of The Great in The People-A Randomclinical Clinical , JAMA Published online June 3, 2020 doi: 10.1001/jamaly.2020.1214